These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697 [TBL] [Abstract][Full Text] [Related]
9. Examination of iatrogenic FDG accumulation after COVID-19 vaccination. Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890 [TBL] [Abstract][Full Text] [Related]
10. Bilateral Avid Axillary Nodes on FDG PET/CT Due to Concurrent Booster COVID-19 Immunization and Seasonal Influenza Vaccination. Nawwar AA; Searle J; Lyburn ID Clin Nucl Med; 2022 Aug; 47(8):712-713. PubMed ID: 35384871 [TBL] [Abstract][Full Text] [Related]
11. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake. Eifer M; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Shams J; Keret N; Gorfine M; Eshet Y J Nucl Med; 2022 Jan; 63(1):134-139. PubMed ID: 33893188 [TBL] [Abstract][Full Text] [Related]
13. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108 [TBL] [Abstract][Full Text] [Related]
14. Frequency and Characteristics of Nodal and Deltoid FDG and Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000 [No Abstract] [Full Text] [Related]
15. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550 [TBL] [Abstract][Full Text] [Related]
16. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers. Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710 [TBL] [Abstract][Full Text] [Related]
17. Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer. Park J; Byun BH; Noh WC; Lee SS; Kim HA; Kim EK; Choi CW; Lim SM Clin Nucl Med; 2014 Apr; 39(4):e249-53. PubMed ID: 24152622 [TBL] [Abstract][Full Text] [Related]
19. Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant? Carkaci S; Adrada BE; Rohren E; Wei W; Quraishi MA; Mawlawi O; Buchholz TA; Yang W Acad Radiol; 2012 May; 19(5):535-41. PubMed ID: 22300741 [TBL] [Abstract][Full Text] [Related]
20. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era. Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]